Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib

Condition:   Inflammatory Bowel Diseases Intervention:   Biological: SHINGRIX Sponsor:   Boston Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials